KLK3 and sexually transmitted disease: In this study, without biomarker outcomes, such as STI diagnoses or the detection of prostate-specific antigen (PSA) and Y-chromosomal DNA, it is not possible to test whether the finding that PrEP did not increase unprotected intercourse is robust to using a more objective measure of that outcome.